Breakthrough Vaccine for Over 60s: mRNA Technology Tackles Respiratory Syncytial Virus
2025-02-28Daily Mail
In a significant development, a new vaccine has been approved for individuals over 60, utilising mRNA technology, similar to the Covid-19 vaccine. The vaccine, developed by Moderna, has been shown to substantially reduce the risk of severe illness fr ...Read more
